The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5231251 6232041 I 5231251-4 20070101 20070126 20070206 EXP US-JNJFOC-20070107452 JOHNSON + JOHNSON PHARMACEUTICAL R+D 41 YR F Y 20070206 CN UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5231251 1008122057 SS TOPAMAX 1 ORAL
5231251 1008122058 PS TOPAMAX 1 ORAL 020505
5231251 1008122059 C ROZEREM 1 ORAL
5231251 1008122060 C WELLBUTRIN 1 ORAL
5231251 1008122061 C LOTREL 1 ORAL
5231251 1008122062 C FIORICET 1 ORAL NOT PRESCRIBED, TAKING FRIEND'S MEDICATION

Indications of drugs used

Event ID DRUG SEQ INDI PT
5231251 1008122058 MIGRAINE PROPHYLAXIS
5231251 1008122059 SLEEP DISORDER THERAPY
5231251 1008122060 DEPRESSION
5231251 1008122061 HYPERTENSION
5231251 1008122062 HEADACHE

Outcome of event

Event ID OUTC COD
5231251 OT

Reactions reported

Event ID PT
5231251 ALOPECIA
5231251 CHEST PAIN
5231251 MIGRAINE
5231251 PALPITATIONS

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found